fxyz
AI eats memory, memory makers cash in
AI data centers need so much memory that the companies making memory chips will stay very busy and earn more.
Result
If held over the last 3 months (Jul 31, 2026 – Oct 30, 2026): −7.4%. Over the same days: Chip stocks +1.9%, S&P 500 +3.4%.
What it holds
- Memory chip makers, 43% of the money, −0.7% over 3 months: MU (Micron), SKHX (SK Hynix), SMSN (Samsung), DRAM (Memory chip fund), CXMT. The companies that make memory chips sell more when AI data centers expand.
- Storage makers, 19% of the money, −29.7% over 3 months: SNDK (Sandisk), KIOXIA (Kioxia), WDC (Western Digital). AI needs places to keep huge amounts of data, so storage makers get busy too.
- Memory chip tool makers, 14% of the money, −14.9% over 3 months: AMAT (Applied Materials), LRCX (Lam Research), ASML. Memory makers must buy more machines to build more chips, which helps the toolmakers.
- AI chip buyers of memory, 19% of the money, +2.4% over 3 months: NVDA (Nvidia), TSM (TSMC), AVGO (Broadcom). The AI chips that use all this memory keep selling, which keeps memory orders coming.
- Cash, 5%.
The plan behind it
AI chips need lots of fast memory sitting right next to them, so every new data center means more memory orders. The biggest part of this portfolio is the companies that make memory chips. Next come the makers of storage drives, which hold all the data AI uses. Then come the companies that sell the machines used to build memory chips. A small slice goes to the AI chip buyers who drive the demand. Everything is a long bet, because each holding gets busier if data centers keep growing.
What would prove it wrong: Big tech companies cut their data center spending, or memory prices start falling hard.
FAQ
How do I bet that AI data centers need so much memory that the companies making memory chips will stay very busy and earn more?
This tested idea holds MU (Micron), SKHX (SK Hynix), SMSN (Samsung), DRAM (Memory chip fund), CXMT, SNDK (Sandisk), KIOXIA (Kioxia), WDC (Western Digital), AMAT (Applied Materials), LRCX (Lam Research), ASML, NVDA (Nvidia), TSM (TSMC) and AVGO (Broadcom), with 5% in cash. Make a copy to run it on practice money first, at real prices.
What would prove it wrong?
Big tech companies cut their data center spending, or memory prices start falling hard.
Can I make one from my own idea?
Yes. Write what you believe in plain words at https://f.xyz/create. fxyz asks a couple of questions, builds the portfolio and shows how it would have done over the last 3 months.
Can I turn a post on X into a theory?
Yes. Reply to the post and tag @fxyzai. It tests the view in the post and replies with the 3-month result and a link.
What can it trade?
Stocks (Tesla, Apple, Nvidia), crypto (Bitcoin, Ethereum, Solana), pre-IPO companies (OpenAI, Anthropic), indices (Nasdaq 100, S&P 500), commodities (gold, silver, oil, copper) and currencies (EUR/USD, USD/JPY). One theory can mix them, and bet for or against any of them.
How does it react to news?
On each check it reads the last two days of news on its biggest holdings and says whether the idea still holds. It can make one small change at a time: trim or drop one holding by up to 5 points. On autopilot the change waits 10 minutes so the owner can skip it; otherwise it asks first.
How do I run it with real money?
For real money, tap Make it mine, open your copy and choose Use real money, with an exchange connected: Hyperliquid, Lighter, Lighter (Robinhood), Backpack, Pacifica or Binance. The money stays in your own account there. fxyz can place trades, but it can never withdraw.
Can the AI get it wrong?
Yes. fxyz's AI turns the idea into holdings, and it can get that wrong: add a coin or stock that doesn't fit, or miss one that does. Check the holdings before you put money in. In your own copy, ask its chat to add or drop any of them.
What do the 3-month numbers mean?
What $100 would have done holding this mix over the last 3 months, at real prices. It is a what-if, not a record: past or simulated results are no promise of future ones, and nothing here is investment advice.